Waardenburg-Shah syndrome

Waardenburg-Shah syndrome, also known as Waardenburg syndrome type 4 (WS4) or Waardenburg-Hirschsprung disease, is a rare genetic disorder that combines features of Waardenburg syndrome (pigmentary abnormalities and sensorineural hearing loss) with Hirschsprung disease (aganglionic megacolon). The condition affects multiple body systems, including the auditory system, skin and hair pigmentation, eyes, and the enteric nervous system of the gastrointestinal tract. Key clinical features include congenital sensorineural hearing loss, heterochromia iridis (different colored eyes) or brilliant blue irides, white forelock or premature graying of hair, patches of skin depigmentation, and Hirschsprung disease characterized by the absence of nerve cells (ganglion cells) in segments of the bowel, leading to severe constipation or intestinal obstruction in the neonatal period. Three genetic subtypes have been identified: WS4A (caused by mutations in the EDNRB gene), WS4B (caused by mutations in the EDN3 gene), and WS4C (caused by mutations in the SOX10 gene). WS4A and WS4B typically follow autosomal recessive inheritance, while WS4C follows autosomal dominant inheritance, though the inheritance pattern can vary. SOX10 mutations (WS4C) may also be associated with neurological features including peripheral demyelinating neuropathy and central dysmyelination (sometimes referred to as PCWH syndrome). There is no cure for Waardenburg-Shah syndrome, and treatment is directed at managing specific symptoms. Hirschsprung disease typically requires surgical intervention (pull-through surgery) to remove the aganglionic segment of bowel. Sensorineural hearing loss may be managed with hearing aids or cochlear implants. Genetic counseling is recommended for affected families. Early diagnosis and multidisciplinary care involving gastroenterologists, otolaryngologists, audiologists, and geneticists are essential for optimal outcomes.

Common questions about Waardenburg-Shah syndrome